• Subscribe
  • About us
  • Advertise with us

NeuroSens

Menu

Skip to content
  • Home
  • Neurology
  • Psychiatry

Topic: MS

Anti-CD20 therapy in MS: comparing efficacy and safety

July 21, 2026  

Highlights of EAN 2026 – Part 2

July 9, 2026  

Highlights of EAN 2026 – Part 1

June 30, 2026  

CLINICAL CASES IN NEUROLOGY – A PERIMENOPAUSAL WOMAN WITH MIGRAINE AND HEAD TRAUMA

May 25, 2026  

CLINICAL CASES IN NEUROLOGY: A 55-y.o. with new MRI lesions

May 19, 2026  

Reducing PIRA with high-efficacy DMTs in MS

May 11, 2026  

AAN DAILY HIGHLIGHTS – WEDNESDAY, APRIL 22, 2026

April 22, 2026  

AAN DAILY HIGHLIGHTS – TUESDAY, APRIL 21, 2026

April 21, 2026  

AAN DAILY HIGHLIGHTS – MONDAY, APRIL 20, 2026

April 20, 2026  

Treatment initiation with ofatumumab: ACTRIMS Forum 2026 highlights

February 19, 2026  
1
2
3
Next

Browse by Topic

  • MS (442)
  • EAN 2026 (2)
  • CLINICAL CASES (21)
  • AAN 2026 (3)
  • ACTRIMS Forum 2026 (4)
  • EPILEPSY (38)
  • AES 2025 (1)
  • BIOMARKERS IN MS (61)
  • ECTRIMS 2025 (7)
  • Library (18)
  • EAN 2025 (2)
  • AAN 2025 (5)
  • ACTRIMS 2025 (6)
  • AES 2024 (1)
  • ECTRIMS 2024 (6)
  • EAN 2024 (3)
  • AD (85)
  • AAN 2024 (5)
  • ACTRIMS Forum 2024 (2)
  • PD (77)
  • COVID-19 (58)
  • MIGRAINE (25)
  • DEPRESSION (36)
  • STROKE (22)
  • SCHIZOPHRENIA (25)
  • DEMENTIA (10)
  • SLEEP (2)
  • PAIN (3)
  • BPD (4)
  • ALS (1)

Popular Posts

  • Proton pump inhibitors linked to neurological conditions posted on November 29, 2019
  • Anti-CD20 therapy in MS: comparing efficacy and safety posted on July 21, 2026
  • Revised recommendations on the differential diagnosis of MS posted on July 25, 2023
Copyright 2026 Lind Publishing Inc All rights reserved. Developed by Integration New Media, INC. (INM)
Contact Us Terms and Conditions